These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4326423)
1. [Blood pressure effects of noradrenaline and angiotensin in hypertensive and normotensive rats]. Scholtysik G Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):444-5. PubMed ID: 4326423 [No Abstract] [Full Text] [Related]
2. A comparative study of the cardiovascular reactivity in various hypertensive and in normotensive rats. Scholtysik G; Unda R Arzneimittelforschung; 1971 Jun; 21(6):891-2. PubMed ID: 4327353 [No Abstract] [Full Text] [Related]
3. Cardiovascular reactivity to noradrenaline and angiotensin in normotensive, hypertensive and 6-hydroxydopamine treated rats. Anokbonggo WW West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):1-8. PubMed ID: 1023507 [TBL] [Abstract][Full Text] [Related]
4. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats. Gan EK; Abas A; Latiff A Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611 [TBL] [Abstract][Full Text] [Related]
5. [Mineralocorticoid-induced changes of vascular reactivity to noradrenaline and angiotensin II in baboons]. Wallrabe D; Gnüchtel U; Bodewei R; Schönfelder G Cor Vasa; 1983; 25(2):154-8. PubMed ID: 6872547 [TBL] [Abstract][Full Text] [Related]
7. Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade. Morato M; Pinho D; Sousa T; Guimarães S; Moura D; Albino-Teixeira A Eur J Pharmacol; 2006 Feb; 531(1-3):209-16. PubMed ID: 16438958 [TBL] [Abstract][Full Text] [Related]
8. Accumulation of 3H-noradrenaline in cardiac and smooth muscle of rats with experimental hypertension. Kazda S; Bibr B Strahlentherapie Sonderb; 1968; 67():376-81. PubMed ID: 4305596 [No Abstract] [Full Text] [Related]
9. [On the vasopressor effect and inactivation of angiotensin in essential and renal as well as experimental hypertension]. Wernze H; Hosoda S; Schölkens B Arch Klin Med; 1968; 214(3):286-305. PubMed ID: 4300861 [No Abstract] [Full Text] [Related]
10. Dietary calcium supplementation prevents the development of hypertension in deoxycorticosterone-salt-treated dogs. Bravo EL; Kageyama Y J Cardiovasc Pharmacol; 1994; 23 Suppl 2():S27-30. PubMed ID: 7518542 [TBL] [Abstract][Full Text] [Related]
11. On the vascular reactivity to angiotensin and noradrenaline in normotensive and spontaneously hypertensive rats. Somova LI Acta Physiol Pharmacol Bulg; 1983; 9(1):51-8. PubMed ID: 6624492 [TBL] [Abstract][Full Text] [Related]
12. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats. Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978 [TBL] [Abstract][Full Text] [Related]
13. [Hypotensive effects of diltiazem in DOCA/saline hypertensive rats (author's transl)]. Yamaguchi I; Ikezawa K; Murata S; Narita H; Ikeo T; Sato M Nihon Yakurigaku Zasshi; 1979 Mar; 75(2):191-9. PubMed ID: 395050 [No Abstract] [Full Text] [Related]
14. Effect of corticosteroids on the cardiovascular responses to angiotensin and norepinephrine. Lefer AM; Manwaring JL; Verrier RL J Pharmacol Exp Ther; 1966 Oct; 154(1):83-91. PubMed ID: 4288615 [No Abstract] [Full Text] [Related]
15. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models. Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358 [TBL] [Abstract][Full Text] [Related]
17. Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations. Tatchum-Talom R; Eyster KM; Martin DS Can J Physiol Pharmacol; 2005 May; 83(5):413-22. PubMed ID: 15897923 [TBL] [Abstract][Full Text] [Related]
19. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652 [TBL] [Abstract][Full Text] [Related]
20. A contrast in vascular reactivity between two kinds of experimental hypertension studied by measurements of the critical opening pressure of tail vessels in the conscious rat. Darke AC; Gaskell P Bibl Anat; 1973; 12():429-36. PubMed ID: 4364113 [No Abstract] [Full Text] [Related] [Next] [New Search]